Human medicines
Denosumab (investigational product)
During a routine quality check, a small number of prefilled syringes were found to contain particles consisting mainly of cellulose fibers. The…
Dancor
The marketing authorization holder has informed its supplied customers in a letter dated 13.09.2013 that investigations have shown that the optimal…
Soliris
The marketing authorization holder informed its supplied customers in a letter dated August 22, 2013, that visible particles were detected in some…
Glucose 40% B.Braun
B. Braun Austria Ges.m.b.H. has informed its supplied customers in a letter dated August 5, 2013, that a customer complaint has informed the marketing…
Fenistil Ampoules
The marketing authorization holder informed its supplied customers in a letter dated July 9, 2013, that in the course of quality assurance measures it…
Thymoglobulin
The distribution partner "sanofi-aventis GmbH" informed its supplied customers in a letter dated 04.07.2013 that the retained samples of the above…
AmBisome
The marketing authorization holder has informed its supplied customers in a letter dated June 19, 2013, that due to a manufacturing problem and the…
Peditrace
The marketing authorization holder informed its supplied customers in a letter dated June 18, 2013, that due to an individual complaint from the…
Cileste, TriCilest und Vivelle
The marketing authorization holder informed its supplied customers in a letter dated June 3, 2013, that in the course of stability tests after 24…
Magnegita
The marketing authorization holder has informed its supplied customers in a letter dated 24.05.2013 that particles were observed in some vials. For…
